Biomedicine and Chemical Sciences (BCS) is an international, peer-reviewed, open-access journal established in 2022 and published quarterly. The journal provides a platform for the publication and dissemination of high-quality research in biomedical sciences, clinical medicine, pharmaceutical sciences, biotechnology, public health, and chemical sciences.

Since its establishment, BCS has been committed to advancing scientific knowledge through rigorous peer review, responsible publishing practices, and unrestricted access to scholarly content. The journal publishes original research articles, review articles, systematic reviews, short communications, and other scholarly contributions relevant to scientific innovation and healthcare advancement.

In 2026, Biomedicine and Chemical Sciences (BCS) underwent a change in its publisher and publishing management. The journal was previously published by International Research and Publishing Academy (iRAPA) and, from 4 June 2026, is published by Biomedicine and Chemical Sciences. The journal continues under the same established title and ISSN identity, while maintaining its existing aims and (BCS) scope, publication ethics, peer-review standards, and scholarly standards.

Journal Information

• Established: 2022
• Frequency: Quarterly
• Peer Review: Double-Blind Peer Review
• Access: Open Access
• Language: English
• ISSN Online: 2790-296X
• ISSN Print: 2957-5826
• Previous Publisher: International Research and Publishing Academy (iRAPA)
• Current Publisher: Biomedicine and Chemical Sciences
• Publisher Change Effective: 4 June 2026